+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Artificial Heart Market 2019-2023 - Product Image

Global Artificial Heart Market 2019-2023

  • ID: 4772975
  • Report
  • May 2019
  • Region: Global
  • 117 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Abbott
  • Abiomed Inc.
  • Medtronic
  • ReliantHeart Inc.
  • SynCardia Systems LLC
  • MORE
Advances in VAD technology will be a key factor driving the growth of the market. The newer generation VADs use several new technologies such as direct flow measurement and remote parameter monitoring and are capable of a wide range of flow for full and/or partial support. They have significantly enhanced survival rates, better quality of life, and device durability with reduced device-related complication rates. Such technological advances and product launches are expected to increase the demand for VADs, which in turn, drives the market. Analysts have predicted that the artificial heart m market will register a CAGR of almost 9% by 2023.

Market Overview

Increasing prevalence of HF and associated risk factors

The prevalence of HF has been steadily increasing in developing as well as developed countries. In Europe, HF affects 20,000 out of one million people in the general population. The prevalence of HF in western countries is estimated to be around 10,000 to 20,000 out of one million individuals, and the average incidence is around 7,500 per million persons each year. Furthermore, the number of hospital admissions due to HF has also been steadily increasing in several countries. This, in turn, will increase the demand for artificial hearts.

High cost of artificial hearts

The high cost of VADs and TAHs is restricting their widespread adoption in developed as well as developing countries. Vendors offering artificial hearts can charge high prices in part due to structural barriers to competition such as the complex and costly regulatory approval process, and patent protection. These barriers hinder the import of artificial hearts that might compete with domestically manufactured devices and reduce the prices. Hence, the high cost of artificial hearts and procedures are hampering the growth of the global artificial heart market.

Competitive Landscape

The market appears to be highly concentrated. The presence of few companies including ReliantHeart Inc. and SynCardia Systems LLC makes competitive environment is quite intense. Factors such as the advances in VAD and increasing prevalence of HF and associated risk factors, will provide considerable growth opportunities to artificial heart manufactures. Abbott, Abiomed Inc., Medtronic, ReliantHeart Inc., and SynCardia Systems LLC are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Abiomed Inc.
  • Medtronic
  • ReliantHeart Inc.
  • SynCardia Systems LLC
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • VAD - Market size and forecast 2018-2023
  • TAH - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Clinical trials for the development of TAHs
  • Focus on development of non-blood-contacting VADs
  • Strategic acquisitions
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Abiomed Inc.
  • Medtronic
  • ReliantHeart Inc.
  • SynCardia Systems LLC
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
PART 15: EXPLORE
    Exhibit 01: Global medical devices market
    Exhibit 02: Segments of global medical devices market
    Exhibit 03: Market characteristics
    Exhibit 04: Market segments
    Exhibit 05: Market definition - Inclusions and exclusions checklist
    Exhibit 06: Market size 2018
    Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
    Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
    Exhibit 09: Five forces analysis 2018
    Exhibit 10: Five forces analysis 2023
    Exhibit 11: Bargaining power of buyers
    Exhibit 12: Bargaining power of suppliers
    Exhibit 13: Threat of new entrants
    Exhibit 14: Threat of substitutes
    Exhibit 15: Threat of rivalry
    Exhibit 16: Market condition - Five forces 2018
    Exhibit 17: Product - Market share 2018-2023 (%)
    Exhibit 18: Comparison by product
    Exhibit 19: VAD - Market size and forecast 2018-2023 ($ millions)
    Exhibit 20: VAD - Year-over-year growth 2019-2023 (%)
    Exhibit 21: TAH - Market size and forecast 2018-2023 ($ millions)
    Exhibit 22: TAH - Year-over-year growth 2019-2023 (%)
    Exhibit 23: Market opportunity by product
    Exhibit 24: Customer landscape
    Exhibit 25: Market share by geography 2018-2023 (%)
    Exhibit 26: Geographic comparison
    Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions)
    Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
    Exhibit 29: Europe - Market size and forecast 2018-2023 ($ millions)
    Exhibit 30: Europe - Year-over-year growth 2019-2023 (%)
    Exhibit 31: Asia - Market size and forecast 2018-2023 ($ millions)
    Exhibit 32: Asia - Year-over-year growth 2019-2023 (%)
    Exhibit 33: ROW - Market size and forecast 2018-2023 ($ millions)
    Exhibit 34: ROW - Year-over-year growth 2019-2023 (%)
    Exhibit 35: Key leading countries
    Exhibit 36: Market opportunity
    Exhibit 37: Impact of drivers and challenges
    Exhibit 38: Vendor landscape
    Exhibit 39: Landscape disruption
    Exhibit 40: Vendors covered
    Exhibit 41: Vendor classification
    Exhibit 42: Market positioning of vendors
    Exhibit 43: Abbott - Vendor overview
    Exhibit 44: Abbott - Business segments
    Exhibit 45: Abbott - Organizational developments
    Exhibit 46: Abbott - Geographic focus
    Exhibit 47: Abbott - Segment focus
    Exhibit 48: Abbott - Key offerings
    Exhibit 49: Abbott - Key customers
    Exhibit 50: Abiomed Inc. - Vendor overview
    Exhibit 51: Abiomed Inc. - Product segments
    Exhibit 52: Abiomed Inc. - Organizational developments
    Exhibit 53: Abiomed Inc. - Segment focus
    Exhibit 54: Abiomed Inc. - Key offerings
    Exhibit 55: Abiomed Inc. - Key customers
    Exhibit 56: Medtronic - Vendor overview
    Exhibit 57: Medtronic - Business segments
    Exhibit 58: Medtronic - Organizational developments
    Exhibit 59: Medtronic - Geographic focus
    Exhibit 60: Medtronic - Segment focus
    Exhibit 61: Medtronic - Key offerings
    Exhibit 62: Medtronic - Key customers
    Exhibit 63: ReliantHeart Inc. - Vendor overview
    Exhibit 64: ReliantHeart Inc. - Product segments
    Exhibit 65: ReliantHeart Inc. - Organizational developments
    Exhibit 66: ReliantHeart Inc. - Key offerings
    Exhibit 67: ReliantHeart Inc. - Key customers
    Exhibit 68: SynCardia Systems LLC - Vendor overview
    Exhibit 69: SynCardia Systems LLC - Product segments
    Exhibit 70: SynCardia Systems LLC - Organizational developments
    Exhibit 71: SynCardia Systems LLC - Key offerings
    Exhibit 72: SynCardia Systems LLC - Key customers
    Exhibit 73: Validation techniques employed for market sizing
    Exhibit 74: Definition of market positioning of vendors
    Note: Product cover images may vary from those shown
    3 of 4

    Loading
    LOADING...

    4 of 4

    FEATURED COMPANIES

    • Abbott
    • Abiomed Inc.
    • Medtronic
    • ReliantHeart Inc.
    • SynCardia Systems LLC
    • MORE
    The analyst recognizes the following companies as the key players in the global artificial heart market: Abbott, Abiomed Inc., Medtronic, ReliantHeart Inc., and SynCardia Systems LLC.

    Commenting on the report, an analyst from the team said: “The latest trend gaining momentum in the market is the clinical trials for the development of TAHs.”

    According to the report, one of the major drivers for this market is the increasing prevalence of HF and associated risk factors.

    Further, the report states that one of the major factors hindering the growth of this market is the high cost of artificial hearts.

    The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
    Note: Product cover images may vary from those shown
    5 of 4
    • Abbott
    • Abiomed Inc.
    • Medtronic
    • ReliantHeart Inc.
    • SynCardia Systems LLC
    Note: Product cover images may vary from those shown
    Adroll
    adroll